Increased innate immune activation induces protective RSV-specific lung-resident memory T cells in neonatal mice.

Young infants frequently experience respiratory tract infections, yet vaccines designed to provide mucosal protection are lacking. Localizing pathogen-specific cellular and humoral immune responses to the lung could provide improved immune protection. We used a well-characterized murine model of respiratory syncytial virus (RSV) to study the development of lung-resident memory T cells (T) in neonatal compared to adult mice. We demonstrated that priming with RSV during the neonatal period failed to retain RSV-specific clusters of differentiation (CD8) T 6 weeks post infection, in contrast to priming during adulthood. The reduced development of RSV-specific T was associated with poor acquisition of two key markers of tissue residence: CD69 and CD103. However, by augmenting both innate immune activation and antigen exposure, neonatal RSV-specific CD8 T cells increased expression of tissue-residence markers and were maintained in the lung at memory time points. Establishment of T correlated with more rapid control of the virus in the lungs upon reinfection. This is the first strategy to effectively establish RSV-specific T in neonates providing new insight into neonatal memory T cell development and vaccine strategies.